A New York-based biotech was turning heads during Tuesday’s session after the company announced that interim results from a phase 2a trial of its HT-001 showed that all...

To read the full story on AllPennyStocks.com, click here.

Hoth Therapeutics (NASDAQ:HOTH)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025 Hoth Therapeutics 차트를 더 보려면 여기를 클릭.
Hoth Therapeutics (NASDAQ:HOTH)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025 Hoth Therapeutics 차트를 더 보려면 여기를 클릭.